期刊
APPLIED AND ENVIRONMENTAL MICROBIOLOGY
卷 74, 期 4, 页码 1076-1086出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AEM.01058-07
关键词
-
The production by filamentous fungi of therapeutic glycoproteins intended for use in mammals is held back by the inherent difference in protein N-glycosylation and by the inability of the fungal cell to modify proteins with mammalian glycosylation structures. Here, we report protein N-glycan engineering in two Aspergillus species. We functionally expressed in the fungal hosts heterologous chimeric fusion proteins containing different localization peptides and catalytic domains. This strategy allowed the isolation of a strain with a functional alpha-1,2-mannosidase producing increased amounts of N-glycans of the Man(5)GlcNAc(2) type. This strain was further engineered by the introduction of a functional GlcNAc transferase I construct yielding GlcNAcMan(5)GlcNac(2) N-glycans. Additionally, we deleted algC genes coding for an enzyme involved in an early step of the fungal glycosylation pathway yielding Man(3)GlcNAc(2) N-glycans. This modification of fungal glycosylation is a step toward the ability to produce humanized complex N-glycans on therapeutic proteins in filamentous fungi.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据